Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. (NLTX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
nltx · market cap & enterprise value · FMP · as of Dec 18, 2023
Core market cap & key metrics
As of Dec 18, 2023, Neoleukin Therapeutics, Inc. (NLTX) has a market cap — also referred to as its net worth or valuation — of $8,199,685, making it one of the top most valuable companies globally. Market Cap = $3.49 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Neoleukin Therapeutics, Inc. (NLTX) has a market cap — also referred to as its net worth or valuation — of $8,199,685 as of Dec 18, 2023, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Neoleukin Therapeutics, Inc. reached its all-time high market cap of $730,732,500 on Dec 31, 2020. Comparing the Neoleukin Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Neoleukin Therapeutics, Inc. net worth vs peers and ask how Neoleukin Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
NLTX market cap · 6 questionsNeoleukin Therapeutics, Inc.'s net worth — measured as market capitalization — is $8,199,685 as of Dec 18, 2023. It ranks #0 globally. Market Cap = $$3.49 (price) × shares outstanding.